STAGE R&D Trainee

Date de mise à jour de l’offre

PEP-Therapy :

PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, our first drug candidate, is currently evaluated in Phase Ia/b clinical trials in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors. For further information:

Description de la mission

Fine-tune the tumor specificity mechanism of PEP-010: study the role played by different components of the apoptosis pathway in different models
Identify additional biomarkers related to the mechanism of action of PEP-010;
Assess the penetrating capacity of cell penetrating peptides

Profil recherché

5-year-university degree or master equivalent;
Area of expertise: cell biology, molecular biology;
Experience in a R&D lab environment, preferably in industry in a start-up environment.

Niveau de qualification requis

Bac + 4/5 et +
  • Employeur
  • Secteur d’activité de la structure
    Enseignement - Formation - Recherche
  • Effectif de la structure
    De 0 à 10 salariés
  • Site internet de la structure
  • Type de stage ou contrat
    Stage pour lycéens et étudiants en formation initiale
  • Date prévisionnelle de démarrage
  • Durée du stage ou contrat
    Plus de 4 mois et jusqu'à 6 mois
  • Le stage est-il rémunéré ?
  • Niveau de qualification requis

    Bac + 4/5 et +
  • Lieu du stage
    PEP-Therapy Gustave Roussy
    114 rue Edouard Vaillant
    94805 VILLEJUIF
  • Accès et transports
    Metro et bus